Lingerie De Peau Invisible Skin-fusion Foundation With Sunscreen Broad Spectrum Spf 20 03 Beige Naturel

Lingerie De Peau Invisible Skin-fusion Foundation With Sunscreen Broad Spectrum Spf 20 03 Beige Naturel Manufacturers

• Guerlain
  

  ×

  Lingerie De Peau Invisible Skin-fusion Foundation With Sunscreen Broad Spectrum Spf 20 03 Beige Naturel | Guerlain

  

  ---

  Shake well before use

  For sunscreen use:

  Apply liberally 15 minutes before sun exposure. Reapply at least every two hours. Use a water resistant sunscreen if swimming or sweating. Sun protection measures.  Spending time in the sun increases your risk of skin cancer and early early skin aging.  To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:     Limit time in the sun, especially from 10 a.m. - 2 p.m.     Wear long-sleeved shirts, pants, hats and sunglasses Children under 6 months:  Ask a doctor.
  

  Close
  No Recall

  More Info
• Guerlain S.a
  

  ×

  Lingerie De Peau Invisible Skin-fusion Foundation With Sunscreen Broad Spectrum Spf 20 03 Beige Naturel | Ranbaxy Pharmaceuticals Inc.

  

  ---

  Levocetirizine dihydrochloride is available as 5 mg breakable (scored) tablets, allowing for the administration of 2.5 mg, if needed. Levocetirizine dihydrochloride tablets can be taken without regard to food consumption.

  2.1 Adults and Children 12 Years of Age and Older

  The recommended dose of levocetirizine dihydrochloride tablets is 5 mg (1 tablet) once daily in the evening. Some patients may be adequately controlled by 2.5 mg (1/2 tablet) once daily in the evening.

  2.2 Children 6 to 11 Years of Age

  The recommended dose of levocetirizine dihydrochloride tablets is 2.5 mg (1/2 tablet) once daily in the evening. The 2.5 mg dose should not be exceeded because the systemic exposure with 5 mg is approximately twice that of adults [see Clinical Pharmacology (12.3)].

  2.4 Dose Adjustment for Renal and Hepatic Impairment

  In adults and children 12 years of age and older with:

  • Mild renal impairment (creatinine clearance [CL CR] = 50 to 80 mL/min): a dose of 2.5 mg once daily is recommended; • Moderate renal impairment (CL CR = 30 to 50 mL/min): a dose of 2.5 mg once every other day is recommended; • Severe renal impairment (CL CR = 10 to 30 mL/min): a dose of 2.5 mg twice weekly (administered once every 3 to 4 days) is recommended; • End-stage renal disease patients (CL CR < 10 mL/min) and patients undergoing hemodialysis should not receive levocetirizine dihydrochloride tablets.

  No dose adjustment is needed in patients with solely hepatic impairment. In patients with both hepatic impairment and renal impairment, adjustment of the dose is recommended.

  Close
  No Recall

  More Info